Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically-induced endometriosis
Endometriosis is a chronic, painful disease characterized by the presence of endometrial glands and stroma outside the uterine cavity. Palmitoylethanolamide (PEA), an endogenous fatty acid amide, has anti-inflammatory and neuroprotective effects. PEA lacks free radical scavenging activity, unlike po...
Saved in:
Main Authors: | Rosanna Di Paola (Author), Roberta Fusco (Author), Enrico Gugliandolo (Author), Rosalia Crupi (Author), Maurizio Evangelista (Author), Roberta Granese (Author), Salvatore Cuzzocrea (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to "Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury" [Pharmacol. Res. 123 (2017) 83-92]
by: Enrico Gugliandolo, et al.
Published: (2024) -
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019) -
PEA/Polydatin: Anti-Inflammatory and Antioxidant Approach to Counteract DNBS-Induced Colitis
by: Alessio Filippo Peritore, et al.
Published: (2021) -
An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
by: Marika Cordaro, et al.
Published: (2020) -
Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
by: Ramona D'Amico, et al.
Published: (2021)